Radiovirotherapy at twenty
- PMID: 37260766
- PMCID: PMC10227365
- DOI: 10.1016/j.omto.2023.05.003
Radiovirotherapy at twenty
Conflict of interest statement
The author declares consulting for Alexion (AstraZeneca), Apellis Pharmaceuticals, Genentech/Roche, Janssen Biotech, Novartis, Ossium Health, and Sanofi. Research funding is provided by K36 Therapeutics and Mayo Clinic through the Department of Development.
References
-
- Dingli D., Peng K.W., Harvey M.E., Greipp P.R., O'Connor M.K., Cattaneo R., Morris J.C., Russell S.J. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood. 2004;103:1641–1646. doi: 10.1182/blood-2003-07-2233. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources